Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,060.00
+1,165.00 (29.91%)
At close: Dec 5, 2025

Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 140.05 billion as of December 5, 2025. Its market cap has increased by 35.48% in one year.

Market Cap
140.05B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
83.86
Stock Price
5,060.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 140.05B, an increase of 386.71%. That is a compound annual growth rate of 5.36%.

History

DateMarket Cap% Change
Dec 5, 2025140.05B41.14%
Dec 30, 202499.22B-12.77%
Dec 28, 2023113.76B-14.20%
Dec 29, 2022132.58B-19.22%
Dec 30, 2021164.12B-22.93%
Dec 30, 2020212.94B47.61%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 76.57T
Celltrion 40.30T
ALTEOGEN 27.86T
ABL Bio 11.08T
SK Biopharmaceuticals 10.53T
Yuhan 8,911.91B
LigaChem Biosciences 6,907.33B
Peptron 6,668.76B
Market Cap Rankings